Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: vaccination

Revisionist History: Seat Belts & Resistance to Public Health Measures

Philip Seo, MD, MHS  |  October 13, 2021

Some were furious. State by state, laws were enacted to ensure compliance. In most states, the laws were accompanied by a modest fine, as an added incentive. By the time the laws were written, most understood they were based on good science and common sense. The potential to save lives and prevent tragedy was finally…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:COVID-19vaccinationvaccine hesitancy

Rohane Hamilton / shutterstock.com

Healthcare Accessibility for People with Rheumatic Disease in New Haven, CT

Vaidehi R. Chowdhary, MD, & Jane E. Dee, BA, MALS  |  October 13, 2021

The COVID-19 pandemic exacerbated wide disparities that exist in the U.S. healthcare system. During the pandemic, the clinical practice in the Section of Rheumatology, Allergy & Immunology at Yale School of Medicine (YSM), New Haven, Conn., rapidly pivoted from face-to-face visits to telehealth to keep our patients and providers safe. Many patients quickly adapted and…

Filed under:Patient PerspectivePractice Support Tagged with:Access to careCOVID-19DisparitiesDr. Lenore Buckleytelehealth

Live Varicella Zoster Vaccine Safe, Effective with TNF Inhibitors

Lisa Rapaport  |  October 6, 2021

(Reuters Health)—Adults 50 years and older who take tumor necrosis factor inhibitors (TNFi’s) for a range of inflammatory disorders can receive effective protection from shingles with a live varicella zoster vaccine, a clinical trial suggests.1 Researchers randomized 617 participants receiving TNFi’s in a 1:1 ratio to receive either the Zostavax live varicella zoster vaccine or…

Filed under:Biologics/DMARDsDrug Updates Tagged with:live vaccinevaccinevaricella zoster vaccinevaricella zoster virus

COVID-19 & Pediatric Rheumatology

Elizabeth Sloan, MD  |  September 14, 2021

PRSYM 2021—Although primary COVID-19 infection has the most significant complications in adult patients, pediatric rheumatologists have also seen significant changes in their practice over the past year. With the emergence of COVID-19, the rise of a mysterious post-COVID hyper­inflammatory syndrome, now known as multisystem inflammatory syndrome in children (MIS-C), was identified, and pediatric rheumatologists have…

Filed under:ConditionsPediatric Conditions Tagged with:COVID-19Multisystem Inflammatory Syndrome in Children (MIS-C)PRSYM

A Look Back at the ACR’s Strong Response to COVID-19

David R. Karp, MD, PhD  |  September 14, 2021

We are now a year-and-a-half into the COVID‑19 pandemic, and rheuma­tologists and rheuma­tology professionals are still facing some of the same challenges that began in spring 2020, as well as new ones. Most recently, we learned that COVID‑19 vaccine efficacy is reduced in some patients on immunosuppressive therapies and the need for additional immunization is…

Filed under:ConditionsLegislation & AdvocacyPediatric ConditionsProfessional Topics Tagged with:COVID-19Hydroxychloroquine (HCQ)Multisystem Inflammatory Syndrome in Children (MIS-C)President's Perspectivetelehealth

Moonshot: Apollo 11, Vaccines & Other Conspiracies

Philip Seo, MD, MHS  |  September 14, 2021

On July 20, 1969, at 10:56 p.m. EDT, American astronaut Neil Armstrong stepped off the lunar landing module, Eagle, and walked on the moon.1 Or so they would have you believe. For most, the basic facts are not in dispute: On May 25, 1961, President John F. Kennedy delivered a speech to a joint session…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:COVID-19vaccine hesitancy

COVID-19 Vaccine Efficacy & Safety Discussed at Town Hall

Ruth Jessen Hickman, MD  |  August 20, 2021

At a recent ACR town hall, panelists described immune responses and side effects of COVID-19 vaccination in patients with rheumatic disease, along with ways to leverage monoclonal antibody treatments, especially in light of virus variants.

Filed under:American College of Rheumatology Tagged with:COVID-19immunosuppressionvaccination

CDC Advisers Consider Boosters for Immune-Compromised Americans

Julie Steenhuysen  |  July 26, 2021

CHICAGO (Reuters)—Advisers to the U.S. Centers for Disease Control & Prevention will consider evidence suggesting that a booster dose of COVID-19 vaccines could increase protection among people with compromised immune systems. Data presented ahead of the July 22 meeting noted that people with compromised immune systems have a reduced antibody response following the recommended primary…

Filed under:Drug Updates Tagged with:CDCCenters for Disease Control and PreventionCOVID-19vaccines

U.S. to Announce New Warning on J&J Coronavirus Vaccine for Guillain-Barré Syndrome

Reuters Staff  |  July 12, 2021

(Reuters)—The U.S. Food & Drug Administration (FDA) is expected to announce a new warning on Johnson & Johnson’s (J&J’s) coronavirus vaccine related to a rare autoimmune disorder, The Washington Post reported on Monday, citing four people familiar with the matter.1 According to The Post, about 100 preliminary reports of Guillain-Barré syndrome have been detected in the…

Filed under:Conditions Tagged with:COVID-19Guillain-Barré SyndromeJohnson & Johnsonvaccine

Researchers Explore Response to COVID-19 Vaccines in the Elderly

Ruth Jessen Hickman, MD  |  July 6, 2021

A delayed second dose of an mRNA vaccine may provide better protection against COVID-19 in elderly patients.

Filed under:Conditions Tagged with:COVID-19elderlyimmunosenescencevaccinationvaccine

  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 24
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences